| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |